[{"AccountsPayableAndAccruedLiabilitiesCurrent_0_Q2_USD":411132000.0,"LiabilitiesCurrent_0_Q2_USD":443344000.0,"NetCashProvidedByUsedInFinancingActivities_2_Q2_USD":-13413000.0,"NetCashProvidedByUsedInInvestingActivities_2_Q2_USD":-191045000.0,"NetCashProvidedByUsedInOperatingActivities_2_Q2_USD":196296000.0,"NetIncomeLoss_1_Q2_USD":12941000.0,"NetIncomeLoss_2_Q2_USD":30312000.0,"LiabilitiesAndStockholdersEquity_0_Q2_USD":5898496000.0,"NetIncomeLossAvailableToCommonStockholdersDiluted_1_Q2_USD":12941000.0,"NumberOfOperatingSegments_2_Q2_Segment":1.0,"OciBeforeReclassificationsBeforeTaxAttributableToParent_1_Q2_USD":-8450000.0,"OciBeforeReclassificationsBeforeTaxAttributableToParent_2_Q2_USD":9498000.0,"OperatingIncomeLoss_1_Q2_USD":11672000.0,"OperatingIncomeLoss_2_Q2_USD":36758000.0,"OtherAccountsPayableAndAccruedLiabilities_0_Q2_USD":4331000.0,"NetIncomeLossAvailableToCommonStockholdersDiluted_2_Q2_USD":30312000.0,"Liabilities_0_Q2_USD":1656925000.0,"InvestmentIncomeInterest_2_Q2_USD":6910000.0,"InvestmentIncomeInterest_1_Q2_USD":4471000.0,"IncomeTaxExpenseBenefit_2_Q2_USD":7072000.0,"IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_2_Q2_USD":-60884000.0,"IncreaseDecreaseInAccountsReceivable_2_Q2_USD":-17420000.0,"IncreaseDecreaseInInventories_2_Q2_USD":-6379000.0,"IncreaseDecreaseInOtherCurrentAssets_2_Q2_USD":-34331000.0,"IncreaseDecreaseInOtherNoncurrentAssets_2_Q2_USD":-321000.0,"IncreaseDecreaseInOtherOperatingLiabilities_2_Q2_USD":585000.0,"IntangibleAssetsNetExcludingGoodwill_0_Q2_USD":394298000.0,"InterestExpense_1_Q2_USD":3817000.0,"InterestExpense_2_Q2_USD":7621000.0,"InterestPaidNet_2_Q2_USD":5195000.0,"InventoryFinishedGoodsNetOfReserves_0_Q2_USD":253304000.0,"InventoryNet_0_Q2_USD":710975000.0,"InventoryRawMaterialsNetOfReserves_0_Q2_USD":83720000.0,"InventoryWorkInProcessNetOfReserves_0_Q2_USD":373951000.0,"OtherAssetsCurrent_0_Q2_USD":99046000.0,"IncomeTaxExpenseBenefit_1_Q2_USD":1215000.0,"OtherAssetsNoncurrent_0_Q2_USD":141663000.0,"OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_2_Q2_USD":15200000.0,"ReclassificationFromAociCurrentPeriodBeforeTaxAttributableToParent_1_Q2_USD":-2334000.0,"ReclassificationFromAociCurrentPeriodBeforeTaxAttributableToParent_2_Q2_USD":-5086000.0,"ResearchAndDevelopmentExpense_1_Q2_USD":161107000.0,"ResearchAndDevelopmentExpense_2_Q2_USD":309832000.0,"RetainedEarningsAccumulatedDeficit_0_Q2_USD":-831297000.0,"RevenueFromContractWithCustomerExcludingAssessedTax_1_Q2_USD":501693000.0,"PurchaseCommitmentRemainingMinimumAmountCommitted_0_Q2_USD":126700000.0,"RevenueFromContractWithCustomerExcludingAssessedTax_2_Q2_USD":987723000.0,"SellingGeneralAndAdministrativeExpense_1_Q2_USD":184161000.0,"SellingGeneralAndAdministrativeExpense_2_Q2_USD":358479000.0,"ShareBasedCompensation_2_Q2_USD":104346000.0,"StockholdersEquity_0_Q2_USD":4241571000.0,"WeightedAverageNumberOfDilutedSharesOutstanding_1_Q2_shares":185427000.0,"WeightedAverageNumberOfDilutedSharesOutstanding_2_Q2_shares":185089000.0,"SalesAndExciseTaxPayableCurrent_0_Q2_USD":1665000.0,"PropertyPlantAndEquipmentNet_0_Q2_USD":1026579000.0,"PropertyPlantAndEquipmentGross_0_Q2_USD":1704705000.0,"ProceedsFromSaleMaturityAndCollectionsOfInvestments_2_Q2_USD":348941000.0,"OtherComprehensiveIncomeLossTaxPortionAttributableToParent1_1_Q2_USD":-173000.0,"OtherComprehensiveIncomeLossTaxPortionAttributableToParent1_2_Q2_USD":-616000.0,"OtherLiabilitiesNoncurrent_0_Q2_USD":105711000.0,"OtherNoncashIncomeExpense_2_Q2_USD":376000.0,"OtherOperatingIncomeExpenseNet_1_Q2_USD":2005000.0,"OtherOperatingIncomeExpenseNet_2_Q2_USD":2863000.0,"PaymentsForProceedsFromOtherInvestingActivities_2_Q2_USD":908000.0,"PaymentsForRepurchaseOfCommonStock_2_Q2_USD":0.0,"PaymentsRelatedToTaxWithholdingForShareBasedCompensation_2_Q2_USD":38731000.0,"PaymentsToAcquireAvailableForSaleSecuritiesDebt_2_Q2_USD":484572000.0,"PaymentsToAcquireIntangibleAssets_2_Q2_USD":6400000.0,"PaymentsToAcquirePropertyPlantAndEquipment_2_Q2_USD":48106000.0,"ProceedsFromConvertibleDebt_2_Q2_USD":0.0,"ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions_2_Q2_USD":27640000.0,"ProceedsFromPaymentsForOtherFinancingActivities_2_Q2_USD":-381000.0,"OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_1_Q2_USD":-5943000.0,"WeightedAverageNumberOfSharesOutstandingBasic_1_Q2_shares":182844000.0,"IncomeTaxesPaid_2_Q2_USD":10159000.0,"IncomeLossFromEquityMethodInvestments_1_Q2_USD":-175000.0,"AvailableForSaleSecuritiesDebtSecuritiesCurrent_0_Q2_USD":481864000.0,"AvailableForSaleSecuritiesDebtSecuritiesNoncurrent_0_Q2_USD":350237000.0,"BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1_2_Q2_USD":4488000.0,"BusinessCombinationContingentConsiderationLiability_0_Q2_USD":63000000.0,"BusinessCombinationContingentConsiderationLiabilityCurrent_0_Q2_USD":32212000.0,"BusinessCombinationContingentConsiderationLiabilityNoncurrent_0_Q2_USD":30760000.0,"AvailableForSaleSecuritiesDebtSecurities_0_Q2_USD":1473634000.0,"CashAndCashEquivalentsAtCarryingValue_0_Q2_USD":641533000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_2_Q2_USD":-7625000.0,"CashFlowHedgeGainLossToBeReclassifiedWithinTwelveMonths_2_Q2_USD":2300000.0,"CommonStockIssuedEmployeeStockTrust_0_Q2_USD":10207000.0,"CommonStockParOrStatedValuePerShare_0_Q2_USD":0.001,"CommonStockSharesAuthorized_0_Q2_shares":500000000.0,"CommonStockSharesIssued_0_Q2_shares":183321820.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_0_Q2_USD":641533000.0,"AvailableForSaleDebtSecuritiesAmortizedCostBasis_0_Q2_USD":1471260000.0,"AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_0_Q2_USD":152000.0,"AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_0_Q2_USD":2526000.0,"AccountsPayableAndOtherAccruedLiabilitiesCurrent_0_Q2_USD":176073000.0,"AccountsReceivableNetCurrent_0_Q2_USD":424419000.0,"AccretionAmortizationOfDiscountsAndPremiumsInvestments_2_Q2_USD":-1878000.0,"AccruedIncomeTaxes_0_Q2_USD":1538000.0,"AccruedRoyaltiesCurrent_0_Q2_USD":17204000.0,"AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_0_Q2_USD":678126000.0,"AccumulatedOtherComprehensiveIncomeLossNetOfTax_0_Q2_USD":-939000.0,"AdditionalPaidInCapitalCommonStock_0_Q2_USD":5083831000.0,"AllocatedShareBasedCompensationExpense_1_Q2_USD":54843000.0,"AllocatedShareBasedCompensationExpense_2_Q2_USD":104346000.0,"AmortizationOfFinancingCostsAndDiscounts_2_Q2_USD":2082000.0,"AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_1_Q2_shares":18504000.0,"AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_2_Q2_shares":18310000.0,"Assets_0_Q2_USD":5898496000.0,"AssetsCurrent_0_Q2_USD":2357837000.0,"CommonStockSharesOutstanding_0_Q2_shares":183321820.0,"IncomeLossFromEquityMethodInvestments_2_Q2_USD":-1526000.0,"CommonStockValue_0_Q2_USD":183000.0,"ComprehensiveIncomeNetOfTax_2_Q2_USD":45512000.0,"EarningsPerShareDiluted_1_Q2_USD":0.07,"EarningsPerShareDiluted_2_Q2_USD":0.16,"EffectOfExchangeRateOnCashAndCashEquivalents_2_Q2_USD":537000.0,"EmployeeRelatedLiabilitiesCurrent_0_Q2_USD":129668000.0,"FinanceLeasePrincipalPayments_2_Q2_USD":1941000.0,"FiniteLivedIntangibleAssetsAccumulatedAmortization_0_Q2_USD":257809000.0,"EarningsPerShareBasic_2_Q2_USD":0.17,"FiniteLivedIntangibleAssetsGross_0_Q2_USD":652107000.0,"GainLossOnDispositionOfAssets1_1_Q2_USD":0.0,"GainLossOnDispositionOfAssets1_2_Q2_USD":0.0,"GainLossOnSaleOfOtherAssets_2_Q2_USD":0.0,"Goodwill_0_Q2_USD":196199000.0,"IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_1_Q2_USD":14156000.0,"IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_2_Q2_USD":37384000.0,"ForeignCurrencyTransactionGainLossUnrealized_2_Q2_USD":1004000.0,"EarningsPerShareBasic_1_Q2_USD":0.07,"DerivativeLiabilitiesCurrent_0_Q2_USD":11034000.0,"DerivativeFairValueOfDerivativeLiability_0_Q2_USD":13929000.0,"ContractWithCustomerLiabilityCurrent_0_Q2_USD":11024000.0,"ConvertibleDebt_0_Q2_USD":1077110000.0,"ConvertibleDebtFairValueDisclosures_0_Q2_USD":1119771000.0,"ConvertibleDebtNoncurrent_0_Q2_USD":1077110000.0,"CostOfRevenue_1_Q2_USD":127062000.0,"CostOfRevenue_2_Q2_USD":247228000.0,"CostsAndExpenses_1_Q2_USD":490021000.0,"CostsAndExpenses_2_Q2_USD":950965000.0,"DebtInstrumentCarryingAmount_0_Q2_USD":1100000000.0,"DeferredIncomeTaxAssetsNet_0_Q2_USD":1431683000.0,"DeferredIncomeTaxExpenseBenefit_2_Q2_USD":1204000.0,"Depreciation_1_Q2_USD":11800000.0,"Depreciation_2_Q2_USD":24300000.0,"DepreciationDepletionAndAmortization_2_Q2_USD":55214000.0,"DerivativeFairValueOfDerivativeAsset_0_Q2_USD":12703000.0,"ComprehensiveIncomeNetOfTax_1_Q2_USD":6998000.0,"WeightedAverageNumberOfSharesOutstandingBasic_2_Q2_shares":182311000.0,"Ticker":"BMRN","CIK":"1048477","name":"BIOMARIN PHARMACEUTICAL INC","OfficialName":"BioMarin Pharmaceutical Inc. Common Stock","form":"10-Q","period":"20210630","fy":"2021.0","fp":"Q2","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"14899091235.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NASDAQ","SP500":"nan","filed":"20210730"}]